DeepLife

Description

DeepLife is a techbio company transforming drug development and sustainable biomanufacturing through AI-powered digital twins of cells. Backed by $10M Series A funding, DeepLife's platform enables researchers to develop precise, cost-effective therapies via cellular simulations and multi-omics analytics.